The ASAM Treatment of Opioid Use Disorder Course- Includes Waiver Qualifying Requirements

Wednesday, July 25
1:00 PM - 5:30 PM

Edwin A. Salsitz, MD, DFASAM

Attending Physician
Mount Sinai Beth Israel
Mount Sinai Beth Israel

Dr. Edwin A. Salsitz has been an attending physician in the Mount Sinai Beth Israel , Division of Chemical Dependency, New York City, since 1983, and is an Assistant Professor of Psychiatry at the Mount Sinai School of Medicine. He is the principal investigator of the Methadone Medical Maintenance (office-based methadone maintenance) research project. Dr. Salsitz is certified by the American Board of Addiction Medicine (ABAM), as well as by the Board of Internal Medicine and Pulmonary Disease. He has published and lectures frequently on addiction medicine topics.
Dr. Salsitz is a course director for ASAM sponsored buprenorphine trainings,
and is a mentor in the PCSS-MAT mentoring program. He has co-chaired the ASAM Review Course, the ASAM Common Threads Course, the ASAM State of the Art course and is a reviewer for the Journal of Addiction Medicine and Drug and Alcohol Dependence. He is the chair of the ASAM REMS course on safe and effective prescribing of opioids. Dr. Salsitz was the Co-chair of the ASAM CME committee and Chair of the New York Society of Addiction Medicine CME and Education committee.
Dr. Salsitz is a member of the medical advisory panel, for the New York State Office of Alcohol and Substance Abuse Services.
Dr. Salsitz is the recipient of the 2014 ASAM Annual Award, and the 2018 ASAM Annual Educator of the Year Award.

Presentation(s):

Send Email for Edwin Salsitz

Adam Gordon, MD MPH FACP DFASAM CMRO

Director
Buprenorphine in the VA Initiative (BIV) & National Coordinator Center for Advanced Interdisciplinary Fellowships in Addiction Treatment
University of Utah School of Medicine

Dr. Gordon is the Elbert F. and Marie Christensen Endowed Research Professor and Professor of Medicine and Psychiatry at the University of Utah School of Medicine and the Section Chief of Addiction Medicine at the Salt Lake City VA Health Care System. Prior to his current appointment, he was a Professor of Medicine and Clinical and Translational Sciences and Advisory Dean at the University of Pittsburgh School of Medicine and VA Pittsburgh Healthcare System. He is a board certified internal medicine (American Board of Internal Medicine) and addiction medicine physician (American Board of Preventive Medicine) and he has achieved status as a Fellow in the American College of Physicians (FACP) and a Distinguished Fellow in the American Society of Addiction Medicine (DFASAM). Since 1998, he is VA Health Services Research and Implementation Scientist since 1998, having received a VA Health Services Research and Development Service (HSR&D) Career Development Award for his research regarding addictions. He has been a Core Faculty member of two Department of Veterans Health Services Research and Development HSRD Centers Of INovations (COINs): The VISN 4 Center for Health Equity and Promotion (CHERP; 2001-2017) and the VA Salt Lake City Informatics, Decision-Enhancement and Analytic Sciences Center (IDEAS2; 2017-present). He has a 20-year track record of conducting research on the quality, equity, and efficiency of health care for vulnerable populations, having received efforts on grants from the NIH, AHRQ, PCORI, VA, SAMHSA and Foundations. He has authored over 178 peer reviewed articles and presented or published hundreds of scholarly work in the area of addictions and vulnerable populations. A major theme of his research include examining the efficacy, effectiveness, and implementation of evidence-based identification, assessment, and treatments for patients with addiction disorders. He is the Director of both the VA’s National Buprenorphine in the VA Initiative and the National Coordinating Center for the VA’s Interdisciplinary Advanced Fellowship in Addiction Treatment. He is a practicing clinician and the Editor-in-Chief of the journal Substance Abuse.

Presentation(s):

Send Email for Adam Gordon


Assets

The ASAM Treatment of Opioid Use Disorder Course- Includes Waiver Qualifying Requirements

Slides

Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for The ASAM Treatment of Opioid Use Disorder Course- Includes Waiver Qualifying Requirements